Zimmer Biomet
1,027 hedge funds and large institutions have $19.2B invested in Zimmer Biomet in 2024 Q4 according to their latest regulatory filings, with 151 funds opening new positions, 303 increasing their positions, 376 reducing their positions, and 85 closing their positions.
78% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 85
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
5% more funds holding
Funds holding: 981 → 1,027 (+46)
2.63% more ownership
Funds ownership: 88.95% → 91.58% (+2.6%)
1% less capital invested
Capital invested by funds: $19.5B → $19.2B (-$271M)
19% less repeat investments, than reductions
Existing positions increased: 303 | Existing positions reduced: 376
26% less call options, than puts
Call options by funds: $62.5M | Put options by funds: $84M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$300M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$219M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$206M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$98M |
| 5 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$82.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$332M |
| 2 |
JP Morgan Chase
New York
|
-$235M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$108M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$96M |
| 5 |
Goldman Sachs
New York
|
-$87.2M |
ZBH Hedge Fund Activity: Q4 2024 in Review
1,027 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2024, worth a combined $19.2B — down 1.4% from $19.5B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new ZBH positions and 85 closed out — a net gain of 66 holders — while 303 added to existing stakes and 376 trimmed.
The largest buyer was Franklin Resources, adding an estimated $300M. The largest seller was Victory Capital Management, cutting an estimated $332M.
- 1,027 institutional investors held Zimmer Biomet (ZBH) as of Q4 2024, up from 981 in Q3 2024.
- Funds reported $19.2B of Zimmer Biomet stock for Q4 2024, down 1.4% quarter-over-quarter.
- 151 funds opened new Zimmer Biomet positions in Q4 2024 and 85 closed out, a net change of +66 holders.
- The largest Zimmer Biomet buyer in Q4 2024 was Franklin Resources, an estimated $300M added.
- The largest Zimmer Biomet seller in Q4 2024 was Victory Capital Management, an estimated $332M sold.
Based on aggregated 13F filings for Q4 2024.